Caris Life Sciences CAI

NASDAQ CAI

$24.80 -0.52 (-2.07%)

As of: Sep 4, 2026 · 2:42 PM EDT

Caris Life Sciences (CAI) Cash & Equivalents (QoQ) (2025 - 2026)

Analysis

Caris Life Sciences (CAI) Cash & Equivalents (QoQ) (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	138.74 Bn	130.89 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.52 Bn	77.52 Bn	3.93 Bn
3	Argenx Se	63.51 Bn	58.32 Bn	1.37 Bn
4	Moderna	58.04 Bn	52.91 Bn	52.00 Mn
5	Revolution Medicines	44.06 Bn	44.06 Bn	-
6	BeOne Medicines	39.98 Bn	34.88 Bn	1.53 Bn
7	Alnylam Pharmaceuticals	35.46 Bn	32.15 Bn	992.69 Mn
8	Royalty Pharma	28.41 Bn	27.57 Bn	-
9	Insmed	27.44 Bn	26.28 Bn	358.27 Mn
10	Caris Life Sciences	7.02 Bn	6.23 Bn	182.38 Mn

Historic Data

Historic Data

Download Data

Date	Value
Jun 30, 2026	-15.86%
Mar 31, 2026	2.93%
Dec 31, 2025	5.71%
Sep 30, 2025	4.76%

Caris Life Sciences

NASDAQ: CAI

$24.80 ▼ -0.52 (-2.07%)

Sep 4, 2026 · 2:42 PM EDT